Kirat Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -13.48%
- Ebitda 13.08%
- Net Worth -73.33%
- Total Assets 1218.44%
About Kirat Lifesciences
Kirat Lifesciences Private Limited (KLPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 May 2018 (Six years and eight months 15 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Gurnam Singh, Satveer Sabharwal, and Kiratveer Sabharwal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51900DL2018PTC334538
-
Company No.
334538
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 May 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Kirat Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurnam Singh
|
Director | 28-May-2018 | Current |
|
Satveer Sabharwal
|
Director | 28-May-2018 | Current |
|
Kiratveer Sabharwal
|
Director | 01-Apr-2020 | Current |
Financial Performance of Kirat Lifesciences.
Kirat Lifesciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 13.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kirat Lifesciences?
Unlock access to Kirat Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Mdc Exports Private LimitedGurnam Singh and Satveer Sabharwal are mutual person
-
Greenbucks Finvest Private Limited
Gurnam Singh and Satveer Sabharwal are mutual person
-
Greenbucks Securities Private Limited
Satveer Sabharwal and Kiratveer Sabharwal are mutual person
-
Greenbucks Consultancy Private Limited
Satveer Sabharwal is a mutual person
-
Greenbucks Comtrade Private Limited
Satveer Sabharwal and Kiratveer Sabharwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kirat Lifesciences?
Unlock and access historical data on people associated with Kirat Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kirat Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kirat Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.